Dr. Sprintz is a national expert on the intersection of chronic pain and addiction, with deep domain expertise in drug testing and digital health automation. He received training at Johns Hopkins and MD Anderson Cancer Center and is triple board-certified in Pain Medicine, Addiction Medicine, and Anesthesiology. He was a member of the Drug Testing Expert Panel of the American Society of Addiction Medicine (ASAM) and currently serves on the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee.
Dr/ Sprintz’s company, Cellarian, creates automated, patient-specific medical necessity documentation and prior authorization letters for clinical reference and physician-owned labs. Cellarian’s platform ensures compliance, optimizes revenue, and decreases audit risk so that labs stay profitable and compliant, and providers can focus on patients, not paperwork.